A functional precision medicine-guided approach appeared to increase PFS among a small cohort of pediatric patients with recurrent and/or refractory solid and hematologic cancers, according to results of a prospective study. The findings, presented at American Association of Cancer Research Annual Meeting, showed the value of functional precision medicine profiling in providing deeper insight